A new Office of Management and Budget (OMB) proposal could fundamentally change how medical research is funded in the United States by removing scientist-led peer review and giving political appointees direct control over which studies receive federal dollars. The proposed rule would affect all federal research grants, including those from the National Institutes of Health (NIH), potentially disrupting clinical trials, medical breakthroughs, and the development of new treatments that reach your doctor's office years from now.

What Would Change Under the Proposed OMB Rule?

Currently, when researchers apply for NIH funding, their proposals go to a panel of scientists with expertise in their field. These peer reviewers evaluate whether the study design is sound, whether the methods are rigorous, and whether the work could meaningfully advance medical knowledge. Only the top 3 to 20 percent of proposals receive funding, based on these expert assessments.

Under the OMB proposal, this system would be dismantled. Three specific changes stand out as particularly damaging to the research ecosystem:

• Political Control of Funding: Political appointees, rather than peer-review panels of scientists, would decide which research gets funded. A poorly designed study could receive money simply because someone in a political office liked the idea, while rigorous, important work might be rejected because it no longer aligns with current administration priorities.
• Mid-Project Cancellations: Federal grants could be canceled at any point without warning, even if a study is halfway through a multi-year project. A cancer study funded for five years could be terminated after two years, leaving researchers, graduate students, and postdoctoral fellows without jobs and patients without answers to questions that could change treatment for hundreds of thousands of people.
• Restricted Communication: Researchers would face barriers to sharing their findings publicly. Federal funds could no longer pay for publication costs in scientific journals, researchers would be restricted from discussing how their findings should inform public health policy, and conferences would need pre-approval from federal agencies, disadvantaging conferences that aren't politically aligned.

Why Does Peer Review Matter for Medical Breakthroughs?

Peer review is the backbone of how American science has operated for generations. It's not a perfect system, and some argue it may undervalue bold, high-risk ideas that could have major payoffs. However, it ensures that funding decisions are based on scientific merit rather than politics.

"Science isn't finished until it's communicated," noted Elisabeth Marnik, PhD, in her analysis of the proposed rule.

Elisabeth Marnik, PhD

The drug that saved your mother's life, the treatment your doctor recommended, the clinical trial that bought someone you love more time: none of it was inevitable. Each required a system built to operate outside politics and sustained over decades, because science doesn't operate on the timeline of a politician.

How Would This Affect Ongoing Research and Careers?

The consequences of mid-project cancellations would be severe. You cannot pause a scientific study the way you pause a subscription. When federal funding stops, everything stops. Research teams that depend on salaries to feed their families would scramble for replacement funding that, in most cases, simply does not exist. Graduate students and postdoctoral researchers would leave their science careers for other paths or even relocate to other countries to continue their work.

The most consequential science, the kind that produces treatments and breakthroughs reaching your doctor's office twenty years from now, is exactly the science that would be abandoned first. Researchers watching this unfold would make a rational decision: don't start anything that will take a decade to finish. This includes not building a team around funding that could vanish or asking the big questions that need patience and stability to answer.

Steps to Make Your Voice Heard on This Proposal

• Submit a Public Comment: The public comment period on this proposed rule is open until July 13, 2026. Anyone can submit a comment, and the OMB is required by law to respond to substantial ones. These comments inform members of Congress, can be used in litigation, and create a public record of opposition or support.
• Contact Your Representatives: Reach out to your congressional representatives and senators to express concerns about how the rule could affect medical research funding and the development of new treatments in your state.
• Share Information: Help spread awareness about the proposed rule and its potential impact on medical research. The more people understand what's at stake, the stronger the public record becomes.

This is still a proposal, which means change is possible. The OMB is required by law to open a public comment period, and those comments matter. They can inform policy decisions, support legal challenges, and create a public record that could be used if the rule is challenged in court.

The stability of federal research funding has allowed the United States to lead the world in medical innovation. The proposed OMB rule threatens that foundation by introducing political uncertainty into a system that requires long-term commitment and scientific expertise to thrive.